Clinical Trial Update: Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Tobramycin for Bacterial Conjunctivitis (C-01-401-004) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing AzaSite (azithromycin ophthalmic solution) to tobramycin for bacterial conjunctivitis assessed clinical and microbial efficacy and safet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Conjunctivitis

Drugs mentioned

• AZASITE (AZITHROMYCIN MONOHYDRATE)
• TOBRAMYCIN (Tobramycin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Bacterial Conjunctivitis | Phase 3 | Status: COMPLETED | Results posted: 2011-10-27